GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+28.77%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$242M
AUM Growth
+$242M
(+19%)
Cap. Flow
+$13.6M
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
44.42%
Holding
91
New
17
Increased
15
Reduced
8
Closed
40
Top Buys
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
$12.1M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$10.5M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$10.1M |
| 4 |
Pacific Biosciences
PACB
|
$9.85M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$9.28M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$16.6M |
| 2 |
AGN
Allergan plc
AGN
|
$10.2M |
| 3 |
Gilead Sciences
GILD
|
$6.87M |
| 4 |
CELG
Celgene Corp
CELG
|
$6.49M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$5.71M |
Sector Composition
| 1 | Healthcare | 90.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVA
1
DELISTED
NuVasive, Inc.
NUVA
| $12.4M | 5.1% | 230,000 +55,000 | +31% | +$2.98M |
|
2
Amgen
AMGN
$155B
| $12.2M | 4.99% | 75,000 +25,000 | +50% | +$4.06M |
|
|
WMGI
3
DELISTED
Wright Medical Group Inc
WMGI
| $12.1M | 4.95% | +500,000 | New | +$12.1M |
|
|
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $11.8M | 4.85% | 230,000 +205,000 | +820% | +$10.5M |
|
|
SAGE
5
DELISTED
Sage Therapeutics
SAGE
| $11.7M | 4.77% | 200,000 +159,200 | +390% | +$9.28M |
|
|
SGEN
6
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.1M | 4.13% | +225,000 | New | +$10.1M |
|
|
MNK
7
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $10.1M | 4.13% | 135,000 +15,000 | +13% | +$1.12M |
|
|
8
Pacific Biosciences
PACB
$393M
| $9.85M | 4.03% | +750,000 | New | +$9.85M |
|
9
Acadia Pharmaceuticals
ACAD
$4.38B
| $8.91M | 3.65% | +250,000 | New | +$8.91M |
|
10
Integra LifeSciences
IART
$1.18B
| $8.13M | 3.33% | 120,000 +45,000 | +60% | +$3.05M |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.9M | 3.23% | +250,000 | New | +$7.9M |
|
|
ZLTQ
12
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $7.85M | 3.21% | 275,000 +40,000 | +17% | +$1.14M |
|
|
BLUE
13
DELISTED
bluebird bio
BLUE
| $7.71M | 3.16% | +120,000 | New | +$7.71M |
|
14
Biogen
BIIB
$19.4B
| $7.66M | 3.14% | +25,000 | New | +$7.66M |
|
|
SPNC
15
DELISTED
Spectranetics Corp
SPNC
| $6.55M | 2.68% | 435,000 +185,000 | +74% | +$2.79M |
|
|
ACHN
16
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $6.47M | 2.65% | 600,000 +300,000 | +100% | +$3.24M |
|
17
Prothena Corp
PRTA
$441M
| $6.13M | 2.51% | +90,000 | New | +$6.13M |
|
|
NSTG
18
DELISTED
NanoString Technologies, Inc.
NSTG
| $5.88M | 2.41% | 400,000 -50,000 | -11% | -$736K |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $5.74M | 2.35% | +85,000 | New | +$5.74M |
|
20
Incyte
INCY
$16.5B
| $5.42M | 2.22% | 50,000 +25,000 | +100% | +$2.71M |
|
|
DBVT
21
DBV Technologies
DBVT
$264M
| $5.31M | 2.18% | +80,000 | New | +$5.31M |
|
|
VTAE
22
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $4.98M | 2.04% | 275,000 +25,000 | +10% | +$453K |
|
|
ACOR
23
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $4.28M | 1.75% | 100,000 | – | – |
|
24
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.24M | 1.73% | +45,000 | New | +$4.24M |
|
|
FPRX
25
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $4.15M | 1.7% | 100,000 -400,000 | -80% | -$16.6M |
|